Page last updated: 2024-10-24

busulfan and Carcinoma, Non-Small Cell Lung

busulfan has been researched along with Carcinoma, Non-Small Cell Lung in 2 studies

Research Excerpts

ExcerptRelevanceReference
"In this study we have used a standardised ATP-based tumour chemosensitivity assay (ATP-TCA) to measure the activity of gefitinib alone or in combination with different cytotoxic drugs (cisplatin, gemcitabine, oxaliplatin and treosulfan) against a variety of solid tumours (n = 86), including breast, colorectal, oesophageal and ovarian cancer, carcinoma of unknown primary site, cutaneous and uveal melanoma, non-small cell lung cancer (NSCLC) and sarcoma."3.72The in vitro effect of gefitinib ('Iressa') alone and in combination with cytotoxic chemotherapy on human solid tumours. ( Cree, IA; Di Nicolantonio, F; Glaysher, S; Johnson, P; Knight, LA; Mercer, S; Sharma, S; Whitehouse, P, 2004)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Knight, LA1
Di Nicolantonio, F1
Whitehouse, P1
Mercer, S1
Sharma, S1
Glaysher, S1
Johnson, P1
Cree, IA1
Köpf-Maier, P1
Sass, G1

Other Studies

2 other studies available for busulfan and Carcinoma, Non-Small Cell Lung

ArticleYear
The in vitro effect of gefitinib ('Iressa') alone and in combination with cytotoxic chemotherapy on human solid tumours.
    BMC cancer, 2004, Nov-23, Volume: 4

    Topics: Adenocarcinoma; Adenosine Triphosphate; Antineoplastic Combined Chemotherapy Protocols; Breast Neopl

2004
Antitumor activity of treosulfan in human lung carcinomas.
    Cancer chemotherapy and pharmacology, 1996, Volume: 37, Issue:3

    Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Anti

1996